Publications by authors named "Daniel F F de Jesus"

Objectives: To develop alginate nanoparticles functionalized with polysorbate 80 (P80) as miltefosine carriers for brain targeting in the oral treatment of cryptococcal meningitis.

Methods: Miltefosine-loaded alginate nanoparticles functionalized or not with P80 were produced by an emulsification/external gelation method and the physicochemical characteristics were determined. The haemolytic activity and cytotoxic and antifungal effects of nanoparticles were assessed in an in vitro model of the blood-brain barrier (BBB).

View Article and Find Full Text PDF

Cryptococcosis therapy is often limited by toxicity problems, antifungal tolerance, and high costs. Studies approaching chalcogen compounds, especially those containing selenium, have shown promising antifungal activity against pathogenic species. This work aimed to evaluate the and antifungal potential of organoselenium compounds against Cryptococcus neoformans.

View Article and Find Full Text PDF

Background: Trichosporon asahii, an emerging fungal pathogen, has been frequently associated with invasive infections in critically ill patients.

Case Report: A 74-year-old male patient diagnosed with COVID-19 was admitted to an Intensive Care Unit (ICU). During hospitalization, the patient displayed episodes of bacteremia by Staphylococcus haemolyticus and a possible urinary tract infection by T.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Daniel F F de Jesus"

  • - Daniel F F de Jesus focuses on innovative antifungal therapies, particularly targeting Cryptococcus neoformans and addressing challenges in treating cryptococcal meningitis and other fungal infections through advanced drug delivery systems and novel compounds.
  • - His research includes the development of miltefosine-loaded alginate nanoparticles that are functionalized for enhanced brain targeting, which demonstrated favorable antifungal effects and physicochemical properties in vitro.
  • - De Jesus also investigates the efficacy of organoselenium compounds, highlighting their potential as effective antifungal agents that can bypass the limitations of traditional therapies, such as toxicity and high costs, particularly against Cryptococcus neoformans.